You just read:

AnTolRx, Inc. Announces Series A Equity Funding from Pfizer, JDRF and Orion Equity Partners, LLC to Develop Targeted Nanoparticle Tolerance Therapeutics

News provided by

AnTolRx, Inc.

08 Sep, 2016, 09:07 ET